A new study links hallucinogen-related emergency department visits to a 21-fold increased risk of schizophrenia compared to ...

The most common side effects of INVEGA HAFYERA® include: injection site reactions, weight gain, headache, upper respiratory ...

People who visit emergency departments because of hallucinogenic drug use are at a heightened risk of developing ...

Researchers conducted a cohort study to assess the predictive value of plasma MMP9 in antipsychotic treatment response among patients with schizophrenia.

Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, ...

People whose use of psychedelics lands them in the ER are at greater risk of schizophrenia They have a 21-fold greater risk ...

Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

It's only during the last few decades that neuroglia, a diverse group of cells found in the brain that perform a variety of ...

For patients with schizophrenia, repetitive transcranial magnetic stimulation (rTMS) was effective and safe in treating ...

AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...

Investing.com - AbbVie (NYSE:ABBV) has announced that its two phase 2 trials of a treatment for adults with schizophrenia ...